H3 K27-altered DMGs variably exhibit aberrant nuclear expression of p53, suggesting a TP53 mutation and loss of α-thalassemia/mental retardation syndrome x-linked (ATRX) expression in approximately 50% and 15% of cases [1,5,8,10]. The gene discussed is TP53; the disease is thalassemia.